Ascus Biosciences, Inc. — Form D
Ascus Biosciences, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-13. The offering totals $5.0M, of which $5.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-06-13
- Form: D
- Accession: 0001672679-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $5.0M
- Investors: 10
- Date of first sale: 2019-05-31
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-341832
Issuer
- Name: Ascus Biosciences, Inc.
- CIK: 0001672679
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 6450 LUSK BLVD SUITES E109/209, SAN DIEGO, CA, 92121
- Phone: 877-696-8945
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Mallory Embree | Director | San Diego, CA |
| Peter Innes | Director | San Diego, CA |
| Jim Kim | Director | San Francisco, CA |
| Michael Seely | Director | San Diego, CA |
| Thad Simons | Director | St. Louis, MO |
| Erik Torgerson | Director | Urbandale, IA |
| Mallory Embree | Executive Officer | San Diego, CA |
| Michael Seely | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More